title: [The effect of dalargin on the opioid and immune systems in patients with a depressive syndrome].
abstract: Depressed patients and healthy donors received dalargin. As shown by the radioreceptor test, the patients recovered normal quantitative and qualitative values of plasma opioid activity due to this drug which is a synthetic agonist of sigma-type opioid receptors. Lymphocyte proliferative activity (spontaneous and induced by polyclonal mitogens) was not significantly different in the test subjects versus the donors, though in vitro studies revealed multidirectional homeostatic effects of dalargin. It is shown that depressions are associated with defective relationships between functions of the immune and opioid system. Dalargin proved uneffective in the treatment of endogenic psychotic depressions, whereas in reactive neurotic depressions and psychosomatic abnormalities the drug is promising and needs further investigations.
authors.forename: A A
authors.initials: AA
authors.lastname: Zozulia
authors.forename: M R
authors.initials: MR
authors.lastname: Shchurin
authors.forename: V I
authors.initials: VI
authors.lastname: Dikaia
authors.forename: V V
authors.initials: VV
authors.lastname: Bondar'
authors.forename: N M
authors.initials: NM
authors.lastname: Krym
authors.forename: G P
authors.initials: GP
authors.lastname: Panteleeva
mesh_terms: D000328:Adult; D000341:Affective Disorders, Psychotic / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured / Q000166:cytology / Q000187:drug effects; D003866:Depressive Disorder / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D004341:Drug Evaluation; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007107:Immune System / Q000187:drug effects*; D008214:Lymphocytes / Q000166:cytology / Q000187:drug effects; D008875:Middle Aged; D017465:Receptors, Opioid, delta / Q000032:analysis / Q000187:drug effects*; D012559:Schizophrenia / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D013997:Time Factors
chemical_list: D017465:Receptors, Opioid, delta; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
vernacular_title: Vliianie dalargina na opioidnuiu i immunnuiu sistemy bol'nykh s depressivnym sindromom.